HNGE EBITDA | Hinge Health, Inc.

Hinge Health, Inc. (HNGE) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income $40.44M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $32.07M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$6.09M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$580.67M; Depreciation and amortization (m).

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	$40.44M	(m)	$212.82M	(m)	$123.00K*	$101.41M*	(m)	$34.06M	(m)	$740.00K
2026-03-31	Reported	(m)	$32.07M	(m)	$182.31M	(m)	$83.00K	$43.08M	(m)	$30.34M	(m)	$814.00K
2025-09-30	Reported	(m)	-$6.09M	(m)	$154.21M	(m)	$52.00K*	$82.40M*	(m)	$31.92M	(m)	$206.00K
2025-06-30	Reported	(m)	-$580.67M	(m)	$139.10M	(m)	$197.00K*	$20.23M*	(m)	$279.96M	(m)	-$326.00K
2025-03-31	Reported	(m)	$13.14M	(m)	$123.83M	(m)	$51.00K	$4.92M	(m)	$23.50M	(m)	$998.00K
2024-09-30	Reported	(m)	-$3.85M	(m)	$100.61M	(m)	$315.00K*	$28.40M*	(m)	$23.79M	(m)	$1.11M
2024-06-30	Reported	(m)	-$17.55M	(m)	$89.83M	(m)	(m)	(m)	(m)	$24.92M	(m)	$361.00K

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$546.37M	(m)	$587.86M	(m)	$708.00K	$171.44M	(m)	$368.14M	(m)	$998.00K
2024-12-31	Reported	(m)	-$31.91M	(m)	$390.40M	(m)	$1.04M	$49.00M	(m)	$100.84M	(m)	$677.00K
2023-12-31	Reported	(m)	-$130.51M	(m)	$292.73M	(m)	$1.98M	-$63.91M	(m)	$110.06M	(m)	-$405.00K